Brief: BioInvent Q1 Sales SEK 5.9 Million

BioInvent International AB

24/04/2024 07:00

Apr 24 (Reuters) - BioInvent Q1 adjusted EPS SEK -1.18.
* Q1 net income SEK -77.9 million
* Q1 adjusted free cash flow SEK -65.9 million